Page last updated: 2024-10-30

methenamine and Porphyria, Acute Intermittent

methenamine has been researched along with Porphyria, Acute Intermittent in 1 studies

Methenamine: An anti-infective agent most commonly used in the treatment of urinary tract infections. Its anti-infective action derives from the slow release of formaldehyde by hydrolysis at acidic pH. (From Martindale, The Extra Pharmacopoeia, 30th ed, p173)
hexamethylenetetramine : A polycyclic cage that is adamantane in which the carbon atoms at positions 1, 3, 5 and 7 are replaced by nitrogen atoms.

Porphyria, Acute Intermittent: An autosomal dominant porphyria that is due to a deficiency of HYDROXYMETHYLBILANE SYNTHASE in the LIVER, the third enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features are recurrent and life-threatening neurologic disturbances, ABDOMINAL PAIN, and elevated level of AMINOLEVULINIC ACID and PORPHOBILINOGEN in the urine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Webber, PR1
Aarsand, AK1
Sandvik, AK1
Skadberg, Ø1
Lindberg, M1
Sandberg, S1

Other Studies

1 other study available for methenamine and Porphyria, Acute Intermittent

ArticleYear
Acute porphyrias may be overlooked in patients taking methenamine hippurate.
    Clinical chemistry and laboratory medicine, 2010, Volume: 48, Issue:9

    Topics: Aged; Aminolevulinic Acid; Artifacts; Diagnostic Errors; Female; Hippurates; Humans; Methenamine; Po

2010